Abstract:Introduction: The U1 small nuclear RNA (snRNA) forms ribonucleoprotein particles (RNPs) such as U1 snRNP and U1-TAF15 snRNP. U1 snRNP is one of the most studied RNPs due to its critical role in pre-mRNA splicing in defining the 5 splice site (5ss) of every exon through direct interactions with sequences at exon/intron junctions. Recent reports support the role of U1 snRNP in all steps of transcription, namely initiation, elongation, and termination. Functions of U1-TAF15 snRNP are less understood, though it associates with the transcription machinery and may modulate pre-mRNA splicing by interacting with the 5ss and/or 5ss-like sequences within the pre-mRNA. An anti-U1 antisense oligonucleotide (ASO) that sequesters the 5 end of U1 snRNA inhibits the functions of U1 snRNP, including transcription and splicing. However, it is not known if the inhibition of U1 snRNP influences post-transcriptional regulation of pre-mRNA splicing through deep intronic sequences. Methods: We examined the effect of an anti-U1 ASO that sequesters the 5 end of U1 snRNA on transcription and splicing of all internal exons of the spinal muscular atrophy (SMA) genes, SMN1 and SMN2 . Our study was enabled by the employment of a multi-exon-skipping detection assay (MESDA) that discriminates against prematurely terminated transcripts. We employed an SMN2 super minigene to determine if anti-U1 ASO differently affects splicing in the context of truncated introns. Results: We observed substantial skipping of multiple internal exons of SMN1 and SMN2 triggered by anti-U1 treatment. Suggesting a role for U1 snRNP in interacting with deep intronic sequences, early exons of the SMN2 super minigene with truncated introns were resistant to anti-U1 induced skipping. Consistently, overexpression of engineered U1 snRNAs targeting the 5ss of early SMN1 and SMN2 exons did not prevent exon skipping caused by anti-U1 treatment. Discussion: Our results uncover a unique role of the U1 snRNA-associated RNPs in splicing regulation executed through deep intronic sequences. Findings are significant for developing novel therapies for SMA based on deep intronic targets.

Suboptimal RNA-RNA interaction limits U1 snRNP inhibition of canonical mRNA 3' processing.

A Potential Mechanism Underlying U1 Snrnp Inhibition of the Cleavage Step of Mrna 3' Processing.

U1 Snrnp Determines Mrna Length and Regulates Isoform Expression

The U1 Antisense Morpholino Oligonucleotide (AMO) Disrupts U1 Snrnp Structure to Promote Intronic PCPA Modification of Pre-Mrnas

U1 Snrnp Proteins Promote Proximal Alternative Polyadenylation Sites by Directly Interacting with 3'end Processing Core Factors

U1 AMO (antisense morpholino oligo) disrupts U1 snRNP structure to promote intronic premature cleavage and polyadenylation (PCPA)

A snoRNA modulates mRNA 3' end processing and regulates the expression of a subset of mRNAs.

Transcriptional Pause Sites Delineate Stable Nucleosome-Associated Premature Polyadenylation Suppressed By U1 Snrnp

U4 Snrnp Inhibits Premature Cleavage and Polyadenylation of Pre-Mrnas

Characterizing Polyadenylated Uarnas Suggests a Potential Role for Pabpn1

U1 snRNA interactions with deep intronic sequences regulate splicing of multiple exons of spinal muscular atrophy genes

A U6 snRNA:pre-mRNA interaction can be rate-limiting for U1-independent splicing.

[The role of the U1 snRNP complex in the regulation of gene expression: recent reports]

Promoter Directionality is Controlled by U1 Snrnp and Polyadenylation Signals

Small nuclear RNAs enhance protein-free RNA-programmable base conversion on mammalian coding transcripts

UPF1 ATPase autoinhibition and activation modulate RNA binding kinetics and NMD efficiency

U1 snRNP-Specific U1C Acts as the Gatekeeper of the Survival of Motor Neurons (SMN) Complex in snRNP Biogenesis

Ilp1 and Ntr1 Affect the Stability of U6 Snrna During Spliceosome Complex Disassembly in Arabidopsis

The U1‐70K and SRSF1 interaction is modulated by phosphorylation during the early stages of spliceosome assembly

SRSF3 and SRSF7 modulate 3′UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels

Interplay between splicing and transcriptional pausing exerts genome-wide control over alternative polyadenylation